Clinical Trial Update: Nuclear Factor Kappa-B (NFKB1) Polymorphism and Organ Injury After Cardiac Surgery

View source ↗

Summary

A completed trial evaluated whether the Nuclear Factor Kappa-B (NFKB1) polymorphism influences the risk of organ injury after cardiac surgery. The study notes o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Lung Injury

Snippet

Sponsor: Changhai Hospital | Conditions: Single Nucleotide Polymorphism, Acute Lung Injury | Status: COMPLETED